Approximately 70% of patients with RA in the Brigham RA Sequential Study registry are reported to be seropositive, which is defined by the presence of either rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA) [34]. Here, PRTN3 is linked to rheumatoid arthritis.